Poly(DL-lactide-co-glycolide) microporous microsphere-based depot formulation of a peptide-like antineoplastic agent

By Shenoy D. B.   D'Souza R. J.   Udupa N.  

Journal of Microencapsulation, Vol. 19, Iss. 4, 2002-07 ,pp. : 523-535

Informa Healthcare

Access to resources Recommend Favorite

Post‐Injection Delirium/Sedation Syndrome after Olanzapine Long‐Acting Intramuscular Injection – Who is at Risk?

By  

BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol. 117, Iss. 3, 2015-09 ,pp. : 213-214

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of olanzapine long-acting injection on levels of functioning among acutely ill patients with schizophrenia

By Witte Michael M.   Case Michael G.   Schuh Kory J.   Ascher-Svanum Haya  

Current Medical Research and Opinion, Vol. 28, Iss. 3, 2012-03 ,pp. : 315-323

Informa Healthcare

Access to resources Recommend Favorite

Real-world use patterns of olanzapine long-acting injection in the United States: comparison to the recommended dosing strategy

By Case Michael G.   Karagianis Jamie L.   Schuh Kory J.   Hoffmann Vicki Poole  

Current Medical Research and Opinion, Vol. 29, Iss. 11, 2013-11 ,pp. : 1533-1537

Informa Healthcare

Access to resources Recommend Favorite

Effect of formulation variables on cis-platin loaded chitosan microsphere properties

By Akbuga J.   Bergisadi N.  

Journal of Microencapsulation, Vol. 16, Iss. 6, 1999-11 ,pp. : 697-703

Informa Healthcare

Access to resources Recommend Favorite